Literature DB >> 8409290

Are antibiotics useful in the management of nontoxic severe ulcerative colitis?

M A Peppercorn1.   

Abstract

Severely ill patients with ulcerative colitis are usually treated with parenteral corticoids. Those with signs of systemic toxicity usually receive antibiotics as well. However, the role of antibiotics in patients without high fever, profound leukocytosis, peritoneal signs or megacolon is not clear. Since 1985, seven patients who were admitted to the hospital with severe ulcerative colitis but without signs of toxicity have received broad spectrum antibiotics. The patients ranged in age from 21 to 65 years: four were male; all were white. Stools for infectious agents were negative. Each patient received intravenous prednisolone at a dose of 60 mg/24 h. After 7 days, each patient continued to have eight to 10 bloody stools per day with low-grade fever and leukocytosis. Institution of broad-spectrum antibiotics was associated with a striking resolution of bloody diarrhea and normalization of temperature. No patient has required colectomy in follow-up of 2-9 years. Whether the antibiotics are treating an undetected pathogen or eliminating non-pathogenic bacteria contributing to the inflammatory process is not clear. I suggest that severely ill patients with ulcerative colitis deserve a trial of antibiotics before being considered failures of medical therapy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8409290     DOI: 10.1097/00004836-199307000-00005

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  3 in total

1.  The Role of Antibiotics in Inflammatory Bowel Disease.

Authors:  Chandrashekhar Thukral; Win J Travassos; Mark A Peppercorn
Journal:  Curr Treat Options Gastroenterol       Date:  2005-06

2.  Diminished efficacy of colonic adaptation to lactulose occurs in patients with inflammatory bowel disease in remission.

Authors:  Andrew Szilagyi; Julie Rivard; Ian Shrier
Journal:  Dig Dis Sci       Date:  2002-12       Impact factor: 3.199

3.  Steroid-refractory ulcerative colitis treated with corticosteroids, metronidazole and vancomycin: a case report.

Authors:  Jonathan Miner; M Monem Gillan; Philip Alex; Michael Centola
Journal:  BMC Gastroenterol       Date:  2005-01-24       Impact factor: 3.067

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.